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Abstract
The assembly of lipid droplets is dependent on PtdIns(4,5)P2 that activates PLD1 (phospholipase D1), which is
important for the assembly process. ERK2 (extracellular-signal-regulated kinase 2) phosphorylates themotor
protein dynein and sorts it to lipid droplets, allowing them to be transported on microtubules. Lipid droplets
grow in size by fusion, which is dependent on dynein and the transfer on microtubules, and is catalysed
by the SNARE (soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptor) proteins
SNAP-23 (23 kDa synaptosome-associated protein), syntaxin-5 and VAMP-4 (vesicle-associated protein 4).
SNAP-23 is also involved in the insulin-dependent translocation of the glucose transporter GLUT4 to the
plasma membrane. Fatty acids induce a missorting of SNAP-23, from the plasma membrane to the interior
of the cell, resulting in cellular insulin resistance that can be overcome by increasing the levels of SNAP-23.
The same missorting of SNAP-23 occurs in vivo in skeletal-muscle biopsies from patients with T2D (Type 2
diabetes). Moreover, there was a linear relation between the amount of SNAP-23 in the plasma membrane
from human skeletal-muscles biopsies and the systemic insulin-sensitivity. Syntaxin-5 is low in T2D patients,
which leads to a decrease in the insulin-dependent phosphorylation of Akt (also known as protein kinase
B). Thus both SNAP-23 and syntaxin-5 are highly involved in the development of insulin resistance.
Introduction
Neutral lipids, such as triacylglycerols or cholesteryl esters,
are stored in lipid droplets in the cytosol. This phenomenon
is preserved throughout evolution and is present in most
mammalian cells [1–4]. For many years, lipid droplets were
considered to be only static fat depots. However, their role
has recently been re-evaluated after observations that they
have a complex surface [4], move in the microtubule network
[5,6] and interact with other organelles such as mitochondria
[7], peroxisomes [8] and the ER (endoplasmic reticulum) [9].
They are thus now regarded as highly dynamic organelles
that play a role in several cellular processes.
Organization of the lipid droplet
Lipid droplets consist of a core of neutral lipids, surrounded
by a monolayer of amphipathic lipids, such as phospholipids
and unesterified cholesterol [2–4]. A number of proteins are
also associated with this monolayer: the best described are the
PAT-domain proteins, which include perilipin, ADFP
(adipocyte differentiation-related protein), TIP47 (47 kDa
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tail-interacting protein), LSDP5 (lipid droplet storage protein
5) and S3-12. Perilipin is expressed only in adipose tissue
and has a dual role: it protects the triacylglycerols from
hydrolysis in its non-phosphorylated state and, in addition,
promotes hydrolysis once phosphorylated (reviewed in [4]).
ADFP has also been suggested to protect the turnover of
triacylglycerols in lipid droplets: overexpression of ADFP
in liver cells prevents fatty acids from entering into other
metabolic pathways such as the formation of very low density
lipoproteins ([10], reviewed in [3,4]).
Several other proteins have also been described in
lipid droplets. They are involved in processes such as
sorting/transport [e.g. Rab, ARF (ADP-ribosylation factor)
and motor proteins] and turnover of lipids [e.g. ATGL
(adipose triacylglycerol lipase) and its co-activator CGI-58,
HSL (hormone-sensitive lipase), DGAT (diacylglycerol
acyltransferase), acyl-CoA synthase and cPLA2 (cytosolic
phospholipase A2)] (reviewed in [4]).
Assembly of lipid droplets (Figure 1)
Lipid droplets are formed from the microsomal membranes
by a process that is dependent on triacylglycerol biosynthesis
[11]. However, several other factors are also of importance
for the assembly process, including PLD1 (phospholipase
D1) [12,13] and PtdIns(4,5)P2 (L. Li, B. Liu, L. Andersson,
E. Lu and S.-O. Olofsson, unpublished work). PLD1
catalyses the formation of phosphatidic acid, a lipid that
is essential for lipid droplet assembly [12,13]. In addition,
the absolute importance of PtdIns(4,5)P2 for the assembly
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Figure 1 The assembly of lipid droplets
The lipid droplets are formed from microsomal membranes. It is proposed that oiling out of triacylglycerols between the
leaﬂets is essential in the assembly process. The assembly process is also dependent on PLD1 and ERK2. ERK2 phosphorylates
dynein and sorts it to droplets. This allows for transfer on microtubules, which is essential for the fusion process that is involved
in the increase in droplet size. The fusion process is catalysed by the SNARE proteins SNAP-23, syntaxin-5 and VAMP-4.
(A) Schematic representation (the SNARE proteins are marked between fusing droplets). (B) Three-dimensional reconstruction
of the assembly process between droplets from time lapse studies recorded by confocal microscopy.
of lipid droplets may, at least partly, be mediated through
activation of PLD1 because a PtdIns(4,5)P2-binding site
[a PH (pleckstrin homology) domain] in PLD1 has been
identified and PtdIns(4,5)P2 is essential for PLD1 activity
[14,15]. Other PtdIns(4,5)P2 targets that have been identified
as important for the formation of lipid droplets include ARF1
(and proteins involved in the regulation of its activity) [16]
and cPLA2 [17].
We also showed that ERK2 (extracellular-signal-regulated
kinase 2) is important for the formation of lipid droplets
[13]. This enzyme phosphorylates the motor protein dynein
and thereby sorts it to lipid droplets [13]. Our results clearly
showed that dynein is essential for lipid droplet fusion (see
below), but also indicated that dynein is involved in the initial
formation of the droplet [13]. However, the details of this
latter process have not been elucidated. One possibility is
that dynein provides a ‘pull force’ that is necessary for the
budding of droplets from the microsomal membrane.
The mechanism for the creation of cytosolic lipid droplets
from the ER is not fully elucidated. One mechanism that
was proposed several years ago (but without substantial
experimental evidence) suggests that, upon formation, tri-
acylglycerols are ‘oiled out’ between the leaflets of the micro-
somal membranes to form a lens that will become the core of
the primordial lipid droplet. The rationale behind this model
is that whereas the triacylglycerol precursors, diacylglycerols
and acyl-CoA, are highly soluble in the cytosolic leaflet
of the microsomal membrane, triacylglycerols have
limited solubility in this leaflet, and are therefore forced
into the hydrophobic part of the membrane (Figure 1)
[3,11].
Growth of lipid droplets (Figure 1)
Newly synthesized lipid droplets are only 0.2 μm in diameter
[11]. However, mature lipid droplets are much larger
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(1–20 μm in diameter), indicating that they are able to grow
after their formation. We demonstrated that they can
grow by homotypic fusion, and that approx. 15 % of all
droplets are engaged in this fusion process at a given time [6].
Although our results indicate that fusion between droplets
is a quantitatively important process, we cannot rule out the
importance of other mechanisms involved in lipid droplet
growth. For example, it has been suggested that the surface
of lipid droplets contain DGAT 2, which catalyses the con-
version of diacylglycerols into triacylglycerols. Thus the
droplets may acquire triacylglycerols by direct biosynthesis
[18]. However, it could be argued that as DGAT 2 is known to
span a bilayer twice [19], substantial adaptation of the enzyme
would be required if it were to fit into the monolayer surface
of the lipid droplet.
Fusion between lipid droplets is dependent on dynein,
which promotes their transport on the microtubule network
[6,13]. Recently, we also showed an involvement of the
SNARE (solubleN-ethylmaleimide-sensitive fusion protein-
attachment protein receptor) proteins SNAP-23 (23 kDa
synaptosome-associated protein), syntaxin-5 and VAMP-4
(vesicle-associated protein 4) [20] and proteins involved in
their regulation, namely NSF (N-ethylmaleimide-sensitive
factor) and α-SNAP (α-soluble NSF-attachment protein)
[20].
The role of SNARE proteins and NSF and α-SNAP in
fusion processes has primarily been investigated in the fusion
process between transport vesicles and target membranes.
Central to the fusion process is the formation of a so-
called four-helix bundle between α-helical domains (SNARE
domains) present in the SNAREs. The formation of this
four-helix bundle forces the membranes together, promoting
their fusion. A detailed molecular model for this process has
recently been proposed [21,22]. The stable four-helix bundle
present after the completion of fusion is unwound by NSF
(an ATPase) and its adaptor protein α-SNAP (for reviews,
see [22–25]).
A transport vesicle is surrounded by a bilayer, whereas the
lipid droplet surface is a monolayer; thus it is likely that there
are differences between the fusion of vesicles and of lipid
droplets. The stalk hypothesis has been proposed to describe
the fusion process between bilayers [24]. We postulate that
fusion between lipid droplets requires fewer steps and is
complete at a stage equivalent to the creation of a ‘fusion
stalk’, i.e. when the two outer monolayers of the bilayers have
fused, and there is a continuum between the hydrophobic
portions of the two membranes. For lipid droplets, this
would correspond to a fusion of the monolayers sur-
rounding the two droplets connecting the two hydrophobic
cores [20].
It should be pointed out that the presence of SNARE
proteins in lipid droplets and the described fusion process
open up the possibility for interactions with other organelles.
Thus a fusion between a lipid droplet and the outer monolayer
of the bilayer around a peroxisome may theoretically result
in a structure very similar to that suggested to be formed
between these two organelles [8].
Figure 2 Tentative roles for SNAP-23 and syntaxin-5 in the
development of insulin-sensitivity
An increased amount of fatty acid, which reaches the skeletal muscle
from, for example, the adipose tissue, results in a redistribution of
SNAP-23 from the plasma membrane to the interior of the cell. This
results in a decreased insulin-dependent translocation of GLUT4 to the
plasma membrane, i.e. insulin resistance. Increased availability of fatty
acids in the skeletal muscle decreases the expression of syntaxin-5,
which leads to a decrease in insulin-dependent activation of Akt, i.e. to
insulin resistance. Thus SNAP-23 and syntaxin-5 are targets by which
different mechanism that affect the insulin-sensitivity in the cell can be
reached.
Lipid droplets and insulin-sensitivity
(Figure 2)
Insulin resistance is one of the most important metabolic
diseases and a risk factor for the development of both
cardiovascular diseases and T2D (Type 2 diabetes).
The glucose turnover in the skeletal muscles is of particular
importance in the development of insulin resistance. The
signalling of insulin, via its receptor, results both in an
increased uptake and an increased utilization of glucose
(glycolysis and oxidation as well as glycogen biosynthesis).
The accumulation of triacylglycerols in skeletal muscles is
highly related to the development of insulin resistance/T2D
[26–29], but the mechanism is not yet clarified and the concept
is complicated by the fact that highly insulin-sensitive ath-
letes, such as marathon runners, have increased levels of tri-
acylglycerols in their muscles [30]. This, and the fact that
triacylglycerols stored in lipid droplets are very inert, argues
against that the triacylglycerols as such are the reason for the
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insulin resistance. Rather it has been proposed that metabolic
products of triacylglycerols and released fatty acids are key
factors in the development of the insulin resistance. Examples
of such products are diacylglycerols, ceramides and partially
oxidized fatty acids [31–34].
Of central importance for the insulin stimulation of the
uptake of glucose is the translocation of the glucose trans-
porter GLUT4 from intracellular storage to the plasma mem-
brane. This process involves the fusion between GLUT4-
specific transport vesicles and the plasma membrane. This
fusion requires the SNARE proteins syntaxin-4, SNAP-23
and VAMP-2 (see for example [35]). Thus SNAP-23 is
involved both in the fusion between lipid droplets and in the
insulin-dependent translocation of the GLUT4 to the plasma
membrane. We used the cardiomyocyte cell line HL-1 cells
to investigate the process. Our results [20] demonstrated that
fatty acids diverted SNAP-23 from the plasma membrane to
the interior of the cell where it was found in lipid droplets.
This resulted in an insulin resistance that could be overcome
by increasing the amount of SNAP-23 in the cell. This opens
up a new model by which triacylglycerols can influence the
insulin-sensitivity, i.e. it is not the triacylglycerols themselves
but proteins involved in their formation and processing
that is of importance. We have recently confirmed the role
of SNAP-23 in in vivo studies in which we compared
skeletal-muscle biopsies from patients with T2D and controls
(P. Bostro¨m, B. Falbe Vind, L. Andersson, L. Ha˚verson, E.
Larsson, J. Perman, J. Bore´n, H. Beck-Nielsen, K. Højlund
and S.-O. Olofsson, unpublished work). We found that
the amount of SNAP-23 in the plasma membrane of the
skeletal-muscle biopsies was much lower in the patients with
diabetes than in the controls. We also found a strong positive
correlation between the amount of SNAP-23 in the plasma
membrane and the systemic insulin-sensitivity measured by
euglycaemic hyperinsulinaemic clamp. Thus the transloca-
tion of SNAP-23 between the plasma membrane and the
interior of the skeletal muscle cell is an important mechanism
for modifying, not only the local, but also the systemic
insulin-sensitivity (P. Bostro¨m, B. Falbe Vind, L. Andersson,
L. Ha˚verson, E. Larsson, J. Perman, J. Bore´n, H. Beck-
Nielsen, K. Højlund and S.-O. Olofsson, unpublished work).
Interestingly, the comparison of skeletal-muscle biopsies
between patients with T2D and controls led us to identify
syntaxin-5, which is also involved in the fusion between lipid
droplets, as important for the development of insulin resist-
ance (P. Bostro¨m, B. Falbe Vind, L. Andersson, L. Ha¨verson,
E. Larsson, J. Perman, J. Bore´n, H. Beck-Nielsen, K. Højlund
and S.-O. Olofsson, unpublished work). Syntaxin-5 was
low in the skeletal muscle from the patients with T2D
and correlated with the insulin-dependent phosphorylation
of Akt (also known as protein kinase B) as a measure of
the insulin signal. Moreover, knockdown of syntaxin-5
in cultured human skeletal-muscle cells, as well as in a
skeletal-muscle cell line, resulted in a decreased insulin-
dependent phosphorylation of Akt. The reason seems to
be that low levels of syntaxin-5 gave rise to increased
levels of diacylglycerols in the cell. This in turn may
be related to the observation that the promotion of
formation [10] and fusion [36] of lipid droplets protects
the hydrolysis of triacylglycerols and prevents degradation
products from triacylglycerols entering into other metabolic
pathways. Thus it is possible that low levels of syntaxin-5
have the opposite effect, allowing diacylglycerols to be
formed from triacylglycerols and enter into other parts of
the cell.
Thus two of the SNARE proteins involved in the
formation of lipid droplets have central roles in the modu-
lation of the insulin-sensitivity. Our results indicate that fatty
acids have a central role in this process and we propose that
SNAP-23 and syntaxin-5 are targets by which fatty acids
from, for example, obese adipose tissue inhibit the insulin-
dependent glucose turnover in the skeletal muscle, leading to
systemic insulin resistance (Figure 2).
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